UNSPSC 51272100: Anaesthetic benzoates

Anaesthetics based on derivatives of benzoic acid.

UNSPSC 51272100 Anaesthetic benzoates is a Class code that in practice covers pharmaceutical procurement for state and local health systems, county health departments, and state health agencies — though recent opportunities tagged under this code show a significant divergence from the nominal scope. The recent solicitations actually involve naloxone (an opioid antagonist, not an anaesthetic benzoate), direct-to-manufacturer pharmacy benefit programs, and multi-source generic pharmaceuticals through cooperative purchasing. State and local governments buying under this code are acquiring naloxone stock for community health initiatives, negotiating pharmacy benefit management arrangements, and sourcing generic drugs and over-the-counter products through authorized wholesaler networks. Issuing bodies include county health departments (Seminole County, Florida), state health agencies (Texas Health and Human Services Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, which serves participating jurisdictions across multiple states including Oregon).

Recent activity spans Florida, Texas, and the upper Midwest. Seminole County, Florida released IFB60459723LAS on June 30, 2026, seeking to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding, with quarterly deliveries to the county community health building and a response deadline of July 26, 2023. Texas HHS issued RFI HHS0017013 on April 3, 2026, to gather vendor capabilities for implementing direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager channels. The Minnesota Department of Administration's MMCAP posted an RFP on January 20, 2026 (due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed across state and local facilities, requiring vendors to work through three authorized wholesalers with cGMP and Drug Supply Chain Security Act compliance, fixed and variable pricing options, and insurance coverage including $5 million commercial general liability. Vendors pursuing this code should note the mismatch between the code's nominal anaesthetic focus and the actual procurement mix, which centers on naloxone, generic pharmaceutical sourcing, and pharmacy benefit innovation.